Pfizer lung cancer drug beats chemo for previously untreated patients

The Pfizer logo is seen outside their world headquarters in New York(Reuters) – Pfizer Inc's Xalkori delayed progression of lung cancer longer than chemotherapy in patients who had never previously been treated for the disease, according to results of a late-stage study released on Tuesday. The medicine, which received U.S. approval in 2011 for lung cancer patients who have a specific gene mutation, had shown in a previous Phase III trial that it significantly delayed disease progression among those who have already undergone chemotherapy for non-small-cell lung cancer, the most common form of the illness. Pfizer said favorable results from the latest trial, combined with those from the earlier big study, establish that Xalkori is appropriate for first-line as well as second-line use, meaning for patients receiving initial treatment as well as for those who have already undergone chemotherapy. The mutation only occurs in a small percentage of patients with lung cancer, but makes them good candidates for treatment with Xalkori.

Ray-Ban maker Luxottica to bring Google Glass to wider market

Developer Firtman wears Google Glass before news conference in RigaBy Stephen Jewkes MILAN (Reuters) – Google has teamed up with Ray-Ban maker Luxottica in a bid to turn its Internet-connected Glass spectacles into a widely-available, stylish consumer product. In a statement late on Monday, Luxottica, the world's biggest eyewear maker, said it had agreed to design, develop and distribute Glass eyewear, which so far has only been available as an expensive prototype in the United States. Google Glass is a small stamp-sized screen attached to a pair of spectacle frames. The deal will allow Italy's Luxottica to be first to showcase the new technology to millions of potential consumers, although Google has yet to surmount challenges such as battery life and privacy concerns.

West African nations scramble to contain Ebola threat

(Blank Headline Received)By Alphonso Toweh and Saliou Samb MONROVIA/CONAKRY (Reuters) – West African nations scrambled on Tuesday to contain an outbreak of the deadly Ebola virus suspected to have killed at least 59 in Guinea, with people presenting symptoms of the disease reported in neighbouring Sierra Leone and Liberia. Health authorities in Liberia said five out of six people who crossed the border from Guinea to seek treatment and showed symptoms of the fever had died. Liberia's Chief Medical Officer Bernice Dahn said it was not confirmed if the cases were Ebola, one of the most lethal infectious diseases known to humans, and tests were being carried out.

China says polluting industry still growing too fast, heavy smog alert for Beijing

An electronic screen and buildings are seen amid heavy smog at the financial district of Pudong in ShanghaiChina's energy-hungry, high-polluting industries continued to grow too fast in 2013, putting "huge pressures" on the environment and causing air quality to worsen, the country's pollution agency said on Tuesday. Premier Li Keqiang "declared war" on pollution in a major policy address this month, but China has long struggled to strike a balance between protecting the environment and keeping up economic growth. China is still too slow in reforming its resource-intensive economy, the Ministry of Environmental Protection said in a statement on its website (www.mep.gov.cn). Slower wind speeds than usual in northern China were an additional contributing factor last year.

CVC buys Nordic optical retail chain Synsam

Private equity firm CVC Capital Partners has bought eyewear chain Synsam Nordic from Alipes, the investment firm controlled by Sweden’s Kamprad family which also controls the world’s largest furniture retailer IKEA, CVC said on Tuesday. CVC did not say how much it paid for Synsam, which had sales of around 3 billion Swedish crowns ($467 million) in 2013 and employs some 2,600. “With attractive market positions, a strong brand name and an extensive store network, as well as an emerging online offering, Synsam is now ready to take the next step in its development,” CVC said in a statement. Synsam is the largest optical retail chain in the Nordic region with more than 420 of its own stores and franchisees in Sweden, Denmark and Norway, CVC added.

1 33 34 35 36 37 104